1AD Ann: 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer - 13th Oct 2022, 8:19am

annb0t

annb0t

Top 20
1AD Ann: 1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer
Price Sensitive: Y
Date: 13th Oct 2022, 8:19am

>>> Read announcement: Google: 1AD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
1AD Ann: Investor Presentation - 27th Oct 2023, 8:27am
Replies
0
Views
608
annb0t
annb0t
annb0t
1AD Ann: Quarterly Appendix 4C and Activities Report - 27th Oct 2023, 8:16am
Replies
0
Views
317
annb0t
annb0t
annb0t
1AD Ann: AD-214 well tolerated in Phase I extension study - 23rd Oct 2023, 8:20am
Replies
0
Views
307
annb0t
annb0t
annb0t
1AD Ann: Letter to Shareholders, Notice of AGM & Proxy Form - 20th Oct 2023, 10:00am
Replies
0
Views
319
annb0t
annb0t
annb0t
1AD Ann: AD-214 oral presentation at MPGPCR23 - 19th Oct 2023, 8:18am
Replies
0
Views
282
annb0t
annb0t
Top Bottom